Perspective Therapeutics (CATX) Total Non-Current Liabilities (2016 - 2026)

Perspective Therapeutics' Total Non-Current Liabilities history spans 16 years, with the latest figure at $62.9 million for Q1 2026.

  • On a quarterly basis, Total Non-Current Liabilities rose 41.15% to $62.9 million in Q1 2026 year-over-year; TTM through Mar 2026 was $62.9 million, a 41.15% increase, with the full-year FY2025 number at $59.6 million, up 18.22% from a year prior.
  • Total Non-Current Liabilities hit $62.9 million in Q1 2026 for Perspective Therapeutics, up from $59.6 million in the prior quarter.
  • Over the last five years, Total Non-Current Liabilities for CATX hit a ceiling of $62.9 million in Q1 2026 and a floor of $2.3 million in Q1 2022.
  • Historically, Total Non-Current Liabilities has averaged $30.5 million across 5 years, with a median of $33.6 million in 2023.
  • Biggest five-year swings in Total Non-Current Liabilities: skyrocketed 713.47% in 2023 and later fell 16.57% in 2025.
  • Tracing CATX's Total Non-Current Liabilities over 5 years: stood at $2.8 million in 2022, then skyrocketed by 713.47% to $22.7 million in 2023, then soared by 121.81% to $50.4 million in 2024, then rose by 18.22% to $59.6 million in 2025, then grew by 5.61% to $62.9 million in 2026.
  • Business Quant data shows Total Non-Current Liabilities for CATX at $62.9 million in Q1 2026, $59.6 million in Q4 2025, and $52.3 million in Q3 2025.